# Retractable Technologies receives $92.8M contract extension from HHS

Retractable Technologies received a preliminary notice from HHS/ASPR expressing intent to exercise all seven one-month option periods under an existing contract, extending it to February 14, 2022 and increasing its value by $92,772,680.

- Type: Contract
- Announced: 2021-06-01
- Where: Little Elm, Texas, United States
- Value: $92.8M
- Status: announced
- Products: safety syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Retractable Technologies](https://endata.com/companies/46988.md)
- [U.S. Department of Health and Human Services](https://endata.com/companies/46441.md) (customer)

## Sources

- [nasdaq.com](https://www.nasdaq.com/press-release/retractable-technologies-inc.-receives-notice-of-intent-to-extend-government-0), 2021-06-01: "Retractable Technologies, Inc. announced today that, in accordance with the 30 day notice requirement, it received a preliminary notice from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (“HHS/ASPR”) expressing its intent to exercis"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.